Guangdong Hybribio Biotech Co Ltd Cash Flow Conversion Efficiency
Guangdong Hybribio Biotech Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Guangdong Hybribio Biotech Co Ltd (300639) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥66.39 Million ≈ $9.71 Million USD) by net assets (CN¥3.73 Billion ≈ $545.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Guangdong Hybribio Biotech Co Ltd (2012–2025)
Cash flow conversion efficiency of Guangdong Hybribio Biotech Co Ltd from 2012 to 2025. This chart illustrates how Guangdong Hybribio Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Guangdong Hybribio Biotech Co Ltd (300639) stock price for real-time trading data and today's change.
Guangdong Hybribio Biotech Co Ltd Cash Flow Conversion Ratio Explained
Guangdong Hybribio Biotech Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Guangdong Hybribio Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangdong Hybribio Biotech Co Ltd ranked by their cash flow conversion efficiency. Also see Guangdong Hybribio Biotech Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ATCO Ltd.
TO:ACO-Y
|
0.047x |
|
Optotech Corp
TW:2340
|
-0.010x |
|
Puyang Refractories Group Co Ltd
SHE:002225
|
0.011x |
|
AB Sagax (publ)
ST:SAGA-D
|
0.038x |
|
Invengo Information Technology Co Ltd
SHE:002161
|
0.016x |
|
Olympic Steel Inc
NASDAQ:ZEUS
|
-0.009x |
|
Yinchuan Xinhua Commercial Group Co Ltd
SHG:600785
|
0.172x |
|
San Bian Science & Technology Co Ltd
SHE:002112
|
-0.116x |
Annual Cash Flow Conversion Efficiency for Guangdong Hybribio Biotech Co Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Guangdong Hybribio Biotech Co Ltd from 2012 to 2025. Review Guangdong Hybribio Biotech Co Ltd (300639) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.66 Billion ≈ $535.84 Million |
CN¥341.61 Million ≈ $49.99 Million |
0.093x | +379.19% |
| 2024-12-31 | CN¥4.05 Billion ≈ $592.14 Million |
CN¥78.78 Million ≈ $11.53 Million |
0.019x | -68.94% |
| 2023-12-31 | CN¥5.10 Billion ≈ $746.11 Million |
CN¥319.60 Million ≈ $46.77 Million |
0.063x | -74.98% |
| 2022-12-31 | CN¥5.23 Billion ≈ $764.86 Million |
CN¥1.31 Billion ≈ $191.58 Million |
0.250x | +37.87% |
| 2021-12-31 | CN¥3.48 Billion ≈ $508.50 Million |
CN¥631.34 Million ≈ $92.39 Million |
0.182x | +47.91% |
| 2020-12-31 | CN¥2.53 Billion ≈ $370.84 Million |
CN¥311.30 Million ≈ $45.55 Million |
0.123x | +28.97% |
| 2019-12-31 | CN¥1.18 Billion ≈ $173.35 Million |
CN¥112.83 Million ≈ $16.51 Million |
0.095x | +27.97% |
| 2018-12-31 | CN¥1.08 Billion ≈ $158.05 Million |
CN¥80.39 Million ≈ $11.76 Million |
0.074x | -8.72% |
| 2017-12-31 | CN¥970.90 Million ≈ $142.07 Million |
CN¥79.17 Million ≈ $11.58 Million |
0.082x | -35.72% |
| 2016-12-31 | CN¥501.67 Million ≈ $73.41 Million |
CN¥63.63 Million ≈ $9.31 Million |
0.127x | +8.26% |
| 2015-12-31 | CN¥413.71 Million ≈ $60.54 Million |
CN¥48.47 Million ≈ $7.09 Million |
0.117x | +16.51% |
| 2014-12-31 | CN¥344.60 Million ≈ $50.43 Million |
CN¥34.65 Million ≈ $5.07 Million |
0.101x | -15.93% |
| 2013-12-31 | CN¥191.38 Million ≈ $28.01 Million |
CN¥22.89 Million ≈ $3.35 Million |
0.120x | -3.12% |
| 2012-12-31 | CN¥130.29 Million ≈ $19.06 Million |
CN¥16.08 Million ≈ $2.35 Million |
0.123x | -- |
About Guangdong Hybribio Biotech Co Ltd
Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-tim… Read more